London, UK, 9 February 2007: BioProgress plc ('BioProgress' or the 'Company')
(AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, has
today announced that it has completed a licensing agreement with Uluru Inc, for
a specific product for the treatment of mouth ulcers using Uluru's Oradisc(TM)
technology.
